Manifestation of pemphigus vulgaris in the orofacial region. Case report

Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae

Volumn 76, Issue 1, 2003, Pages 55-62

  Fassmann, A ^a   Dvorakovan N ^a   Izakovicova Holla L ^a   Vanek J ^a   Wotke, J ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Autoimmune disease; Bullae; Mucous membrane; Pemphigus vulgaris

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

AGED; ARTICLE; AUTOIMMUNE DISEASE; BLISTER; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; FACE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LOWER LIP; MOUTH; MOUTH CAVITY; MUCOSA; PEMPHIGUS VULGARIS; SKIN DISEASE; SYMPTOMATOLOGY;

EID: 0037952913     PISSN: 12113395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bickle K, Roak TR, Hsu S. Autoimmune bullous dermatoses: review. Am Fam Physician 2002; 65:1861-1870.
2. Civatte A. Diagnostic histopahologique de la darmatite polymorphe doloureuse on maladie de Duhring-Brocq. Ann. dermat. et syph. 1943; 3: 1.
3. Tzanck A., Bonergeois-Gavardin B., Brunetiere R. Le cytodiagnostic immédiat en dermatologie. Ann dermat et syph 1948; 8: 205-218.
4. Beutner EH, Jordon RE. Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining. Proc Soc Exp Biol (N. Y.) 1964; 117: 505-510.
5. Beutner EH, Lever WF, Witebsky E, Jordon RE, Chertock B. Antibodies in pemphigus vulgaris. Response to an intercellular substance in epidermis. J Amer Med Ass 1965; 192: 682-688.
6. Hertl M, Veldman C. Pemphigus - paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol Appl Skin Physiol 2001; 14: 408-418.
7. Costello MJ, Jaimovich L, Dannenberg M. Treatment of pemphigus with corticosteroids. J Amer Med Ass 1957; 165: 1249.
8. Krain LS, Terasaki PI, Newcomer VD, Mickey MR. Increased frequency of HL - A 10 in pemphigus vulgaris. Arch Derm 1973; 108: 803-805.
9. Scully C, Challacombe SJ. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations and management. Crit Rev Oral Biol Med 2002; 13: 397-408.
10. Lever WF. Pemphigus and Pemphigoid. Ch. C. Thomas, Springfield, 1965: 266 pp.
11. Lehmann R, Landau JW, Newcomer VD. Pemphigus vulgaris in a twelve-year-old boy. J Pediatr 1965; 67: 264-9.
12. Nousari HC, Anhalt GJ. Pemphigus and pemphigoid. Lancet 1999; 354: 667-672.
13. Stanley JR. Pemphigus and pemphigoid as paradigms of organs-specific, autoantibody-mediated diseases. J Clin Invest 1989; 83: 1443-1448.
14. Anhalt GJ, Diaz LA. Research advances in pemphigus. J Amer Med Ass 2001; 285: 652-654.
15. Vlašín Z. Involvement of autoallergic phenomena in the inflammatory reaction of skin. Dissertation. Masaryk University Brno, 1965; 193 p.
16. Dahl MV, Katz SI, Scott R, Binn LN. Viral studies in pemphigus. J Invest Derm 1974; 62: 96-99.
17. Korman NJ, Eyre RW, Zone J, Stanley JR. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. I Invest Dermatol 1991; 96: 273-276.
18. Tsankov N, Dimitrova J, Obreschkowa E, Lasarowa A. Induzierter Pemphigus dutch das Pestizid Phosphamid. Z Hautkr 1987, 62, 3, 196-201.
19. Fraser NG, Kerr NW, Donald D. Oral lesions in dermatitis herpetiformis. Brit J Dermatol 1973; 89: 439-50.
20. Econopoulos P, Lascaris G. Dermatitis herpetiformis. Oral lesion as an early manifestation. Oral Surg Oral Med Oral Pathol 1986; 62: 77-80.